Report cover image

Genetic Toxicology Testing Market Size, Share & Trends Analysis Report By Type (In Vitro, In Vivo), By Product (Reagents & Consumables, Assay Kit, Services), By Assay (Comet Assay, Micronucleus Assay, Chromosomal Aberration Test), By Application, By Regio

Publisher Grand View Research
Published Nov 21, 2025
Length 120 Pages
SKU # GV20649672

Description

Genetic Toxicology Testing Market Summary

The global genetic toxicology testing market size was valued at USD 1.62 billion in 2024 and is projected to reach USD 4.53 billion by 2033, expanding at a CAGR of 12.13% from 2025 to 2033. The industry is increasing due to several factors, including the growing prevalence of cancer, breakthroughs in genomics technology, research and development in the chemical, pharmaceutical, and biotechnology industries, the shift toward precision and personalized medicine, and increasing public awareness of the health risks associated with exposure to genotoxic agents.

Technological Advancements

The market for genetic toxicology testing is driven largely by technological advancements, which are transforming conventional testing paradigms and enhancing the precision, speed, and predictive value of genotoxic evaluations. By allowing for the simultaneous testing of thousands of samples, the integration of high-throughput screening (HTS) platforms has greatly accelerated compound evaluation, cutting costs and development timelines.

Moreover, the market's potential for growth has been further enhanced by the integration of artificial intelligence (AI) and machine learning (ML) into toxicology testing. In addition to increasing testing efficiency, this shift toward data-driven, computational toxicology is also aligned with international regulatory efforts that support non-animal, in silico, and in vitro testing methods.

Cosmetic and Chemical Safety Assessment

As consumers and regulatory bodies place a greater emphasis on product safety and sustainability, the growing demand for genetic toxicology testing is largely driven by the expanding sectors of cosmetics, agrochemicals, and industrial chemicals. The need to assess the potential mutagenic and carcinogenic effects of chemicals and cosmetic ingredients on human health and the environment is increasing as their production expands globally.

Moreover, manufacturers are being compelled to invest in thorough genotoxicity evaluations due to growing consumer awareness of product safety and the growing demand for "clean," non-toxic, and environmentally friendly formulations. To evaluate DNA damage, chromosomal abnormalities, and mutagenic potential in complex formulations, businesses utilize sophisticated cell-based assays, 3D tissue models, and microfluidic systems.

Global Genetic Toxicology Testing Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global genetic toxicology testing market report on the basis of product, type, assay, application, and region:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Reagents & Consumables
  • Assays Kit
  • Services
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • In Vitro
  • In Vivo
  • Assay Outlook (Revenue, USD Million, 2021 - 2033)
  • Comet Assay
  • Micronucleus Assay
  • Chromosomal Aberration Test
  • Genetic Mutation Test
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology
  • Food Industry
  • Cosmetics Industry
  • Other
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Assay Segment
1.2.3. Application Segment
1.2.4. Type Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Driver Analysis
3.3.1. Increasing regulatory requirements for drug safety assessments
3.3.2. Rising demand for early-stage toxicity screening in drug development
3.3.3. Advancements in non-animal testing methods and technologies
3.4. Market Restraint Analysis
3.4.1. High costs of advanced testing technologies
3.4.2. Lack of standardized testing protocols across industries
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
Chapter 4. Product Business Analysis
4.1. Segment Dashboard
4.2. Global Genetic Toxicology Testing Market: Product Movement Analysis
4.3. Reagents & Consumables
4.3.1. Reagents & Consumables Market, 2021 - 2033 (USD Million)
4.4. Assays Kit
4.4.1. Assays Kit Market, 2021 - 2033 (USD Million)
4.5. Services
4.5.1. Services Market, 2021 - 2033 (USD Million)
Chapter 5. Type Business Analysis
5.1. Segment Dashboard
5.2. Global Genetic Toxicology Testing market: Type Movement Analysis
5.3. In Vitro
5.3.1. In Vitro Market, 2021 - 2033 (USD Million)
5.4. In Vivo
5.4.1. In Vivo Market, 2021 - 2033 (USD Million)
Chapter 6. Assay Business Analysis
6.1. Global Genetic Toxicology Testing market: Assay Movement Analysis
6.2. Comet Assay
6.2.1. Comet Assay Market, 2021 - 2033 (USD Million)
6.3. Micronucleus Assay
6.3.1. Micronucleus Assay Market, 2021 - 2033 (USD Million)
6.4. Chromosomal Aberration Test
6.4.1. Chromosomal Aberration Test Market, 2021 - 2033 (USD Million)
6.5. Genetic Mutation Test
6.5.1. Genetic Mutation Test Market, 2021 - 2033 (USD Million)
6.6. Others
6.6.1. Others Market, 2021 - 2033 (USD Million)
Chapter 7. Application Business Analysis
7.1. Segment Dashboard
7.2. Global Genetic Toxicology Testing Market: Application Movement Analysis
7.3. Pharmaceutical & Biotechnology
7.3.1. Pharmaceutical & Biotechnology Market, 2021 - 2033 (USD Million)
7.4. Food Industry
7.4.1. Food Industry Market, 2021 - 2033 (USD Million)
7.5. Cosmetics Industry
7.5.1. Cosmetics Industry Market, 2021 - 2033 (USD Million)
7.6. Other
7.6.1. Other Market, 2021 - 2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Global Genetic Toxicology Testing Market Share By Region, 2024 & 2033
8.2. North America
8.2.1. North America genetic toxicology testing market, 2021 - 2033 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. U.S. genetic toxicology testing market, 2021 - 2033 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Canada genetic toxicology testing market, 2021 - 2033 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Competitive Scenario
8.2.4.3. Regulatory Framework
8.2.4.4. Mexico genetic toxicology testing market, 2021 - 2033 (USD Million)
8.3. Europe
8.3.1. Europe genetic toxicology testing market, 2021 - 2033 (USD Million)
8.3.2. Germany
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Germany genetic toxicology testing market, 2021 - 2033 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. UK genetic toxicology testing market, 2021 - 2033 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. France genetic toxicology testing market, 2021 - 2033 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Italy genetic toxicology testing market, 2021 - 2033 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Spain genetic toxicology testing market, 2021 - 2033 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Denmark genetic toxicology testing market, 2021 - 2033 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Sweden genetic toxicology testing market, 2021 - 2033 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Norway genetic toxicology testing market, 2021 - 2033 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific genetic toxicology testing market, 2021 - 2033 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Japan genetic toxicology testing market, 2021 - 2033 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. China genetic toxicology testing market, 2021 - 2033 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. India genetic toxicology testing market, 2021 - 2033 (USD Million)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. South Korea genetic toxicology testing market, 2021 - 2033 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Australia genetic toxicology testing market, 2021 - 2033 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Thailand genetic toxicology testing market, 2021 - 2033 (USD Million)
8.5. Latin America
8.5.1. Latin America genetic toxicology testing market, 2021 - 2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Brazil genetic toxicology testing market, 2021 - 2033 (USD Million)
8.5.3. Argentina
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Argentina genetic toxicology testing market, 2021 - 2033 (USD Million)
8.6. MEA
8.6.1. MEA genetic toxicology testing market, 2021 - 2033 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. South Africa genetic toxicology testing market, 2021 - 2033 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Saudi Arabia genetic toxicology testing market, 2021 - 2033 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. UAE genetic toxicology testing market, 2021 - 2033 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Kuwait genetic toxicology testing market, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Laboratory Corporation of America Holdings
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Eurofins Scientific
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Thermo Fisher Scientific, Inc.
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Charles River Laboratories
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Jubilant Ingrevia Limited
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Syngene International Limited
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Gentronix
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Inotiv
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Creative Bioarray
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. MB Research Laboratories.
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us